Laurel Wealth Advisors (North Carolina)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4	Closed	-$113	–	598
2022 Q4	$113	Buy	+4	New	+$127	﹤0.01%	549
2021 Q3	–	Sell	-102	Closed	-$9K	–	671
2021 Q2	$9K	Hold	102	–	–	﹤0.01%	465
2021 Q1	$9K	Sell	102 -50	-33%	-$4.96K	﹤0.01%	433
2020 Q4	$14K	Sell	152 -48	-24%	-$3.82K	﹤0.01%	382
2020 Q3	$13K	Hold	200	–	–	﹤0.01%	361
2020 Q2	$10K	Hold	200	–	–	﹤0.01%	377
2020 Q1	$6K	Hold	200	–	–	﹤0.01%	394
2019 Q4	$7K	Hold	200	–	–	﹤0.01%	412
2019 Q3	$6K	Hold	200	–	–	﹤0.01%	411
2019 Q2	$7K	Sell	200 -50	-20%	-$1.6K	﹤0.01%	400
2019 Q1	$8K	Hold	250	–	–	﹤0.01%	386
2018 Q4	$6K	Buy	+250	New	+$7.04K	﹤0.01%	392

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s ARKG Position: Q1 2023 in Review

Laurel Wealth Advisors (North Carolina) sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 4 shares — an estimated $113 sold.

Laurel Wealth Advisors (North Carolina) first reported a position in ARKG in Q4 2018 and held it in 12 quarters. The position peaked at $14K in Q4 2020. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Laurel Wealth Advisors (North Carolina) reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Laurel Wealth Advisors (North Carolina) sold 4 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $113.
Laurel Wealth Advisors (North Carolina) first reported a position in ARK Genomic Revolution ETF in Q4 2018 and held it in 12 quarters.
Laurel Wealth Advisors (North Carolina)'s ARK Genomic Revolution ETF position peaked at $14K in Q4 2020.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2023, filed 8 May 2023.